Authors


Sonal Parasrampuria, PhD, MPH

Latest:

Effects of an Out-of-Pocket Maximum in Medicare Part D

This study compares the impact of the 3 different out-of-pocket maximums proposed in Congress and by the Medicare Payment Advisory Commission.


Kelly Procailo, PharmD, BCOP

Latest:

The Impact of Immune Checkpoint Inhibitors on Cost and Quality of Life in the Initial Treatment of Patients With Advanced or Metastatic NSCLC

Immune checkpoint inhibitors (ICIs) represent a significant benefit for the initial treatment of patients with advanced or metastatic non−small cell lung cancer (NSCLC). Beyond clinical benefit of increased overall survival, it represents a class of medications with a favorable adverse effect profile compared with chemotherapy. Drugs that target programmed cell death protein 1 (PD-1) receptor and its ligand PD-L1 are ICIs that work by taking the brakes off the immune system and promote T-cell−mediated cancer cell destruction. Current NCCN guidelines recommend that all patients with advanced or metastatic NSCLC have their PD-L1 status (amount of PD-L1 on cancer cells) assessed to guide treatment section. However, this recommendation is not always followed and may lead to inappropriate treatment selection and potential increased cost. Through appropriate biomarker testing, subsequent appropriate utilization of ICIs may help to drive down other costs and improve health-related quality of life. Managed care pharmacists should continue to focus on promotion of guideline concordant care that includes appropriate biomarker testing and selection of an evidence-based preferred treatment option.



Ru Peng Mong, MBBS

Latest:

Evaluating Smoking Cessation Service at an Emergency Department Clinical Observation Unit

This study aimed to evaluate the impact of a smoking cessation service in a group of patients admitted to a short-stay unit in the emergency department.


Jane Sullivan, MPH

Latest:

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.


Tracy Mahvan, PharmD, MBA, BCGP

Latest:

Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.


Callie Coombs, MD

Latest:

Reflections on 2024’s Progress in R/R CLL

Panelists discuss how the relapsed/refractory chronic lymphocytic leukemia treatment landscape evolved significantly in 2024 with expanded Bruton tyrosine kinase inhibitor options, growing real-world evidence for newer agents, and emerging combination strategies, while expressing optimism for future advances in personalized therapy approaches and novel drug development.


Raj Chovatiya, MD, PhD, MSCI

Latest:

Lebrikizumab Shows Promise in Long-Term Atopic Dermatitis Control: Raj Chovatiya, MD, PhD

Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those with prior biologic use, positioning it as a potential first-line treatment for moderate to severe atopic dermatitis.


J. Dawn Abbott, MD

Latest:

Limited English Proficiency, Cardiovascular Risk Factors, Cardiovascular Disease, and In-Hospital COVID-19 Outcomes

This study evaluated whether limited English proficiency modifies the association between cardiovascular risk factors or cardiovascular disease and outcomes in patients hospitalized with COVID-19.


Morgane C. Mouslim, DVM, ScM

Latest:

Cross-Validation of Insurer and Hospital Price Transparency Data

Real-world cross-validation of insurer and hospital price transparency data finds low overlap but high concordance between data sources.


Martin Rosenzweig, MD

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.


Marius Hoeper, MD

Latest:

Addressing Unmet Needs in the PAH Landscape

Marius Hoeper, MD, describes the role clinicians can play in advocating for health care system reforms that could address the economic implications of PAH and discusses the key unmet needs in the PAH treatment landscape.


K. Dennie Kim, PhD

Latest:

Care Fragmentation Predicts 90-Day Durable Ventricular Assist Device Outcomes

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.


Hsiu-Wen Kuo, MSN

Latest:

Impact of COVID-19 Pandemic on Accessibility of Taiwanese Medical Care

The COVID-19 pandemic disrupted access to routine medical care in community populations in Taiwan. The unmet needs should be emphasized as normal life resumes.


Colleen Ereditario, MPH, RD, LDN

Latest:

Frameworks for Advancing Health Equity: Food as Medicine

Learn about how Allegheny Health Network's "Food as Medicine" initiative tackles food insecurity and enhances health through personalized nutrition support.


Lauren Buchanan, MA

Latest:

Psoriasis Treatment Center of New Jersey Reports Positive Results for Tapinarof in Psoriasis Trial

In this study, 52% of adult patients achieved the treat-to-target goal of 1% BSA or less within 3 months of incorporating tapinarof cream into their biologic regimen.



Zachary A. Allon, BA

Latest:

Care Coordination Engagement Patterns in Long-Term Patients

Care coordination engagement increases over time in long-term high-cost, high-need patients, with no identifiable data-driven times for when to initiate patient care de-escalation.


Juan Troy, EdS, MBA, PMP, CPC, CPC-P, COC

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


Mindy M. Cheng, PhD, MS

Latest:

US Cost-effectiveness and Budget Impact of Point-of-Care NAAT for Streptococcus

This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.


Lauren Massaro

Latest:

Researchers Propose Model to Replicate Patient Experience in Artificial Pancreas System

A methodology to monitor patient-in-the-loop modes and faults was examined using a hybrid automata model that was able to replicate patient’s real-life operation modes.


Aimee M. Near, MPH

Latest:

Real-world HIV Diagnostic Testing Patterns in the United States

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.


Matthew R. Augustine, MD, MS

Latest:

Growth of Electronic Consultations in the Veterans Health Administration

This study evaluates the growth in electronic consultation use over the first 7 years after its implementation across the entire Veterans Health Administration system.


Miku Sodhi, MBBS, MHA

Latest:

Ensuring Access to Health Care by FQHCs as States Reopen Amid COVID-19

Federally qualified health centers (FQHCs) must focus on enhancing the nonemergency medical transportation Medicaid benefit to improve patient access during the coronavirus disease 2019 (COVID-19) emergency as states reopen.


Milena Sullivan, MA

Latest:

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.




Eliza Shulman, DO

Latest:

Advanced Care at Home at Scale in an Integrated Health Care System

Advanced care at home (otherwise known as hospital at home) can be scaled and provide care for a sizable portion of a hospital’s inpatient census, creating hospital capacity in an integrated delivery system.


Thearis A. Osuji, MPH

Latest:

Contemporary Care Patterns in the Management of Small Renal Masses

An investigation of management patterns after initial radiographic diagnosis of small renal masses showed that early urologist referral was associated with guideline-concordant care.


Dan Bloomfield, MD | image credit: anthostherapeutics.com
Dan Bloomfield, MD

Latest:

Abelacimab Shows Potential to Shift the Standard of Care in AFib

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo